Name | Miller's Merry Manor |
---|---|
Location | 1720 Alber St, Wabash, Indiana |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 44 |
Occupancy Rate | 50.45% |
Medicare ID (CCN) | 155627 |
Legal Business Name | Johnson Memorial Hospital |
Ownership Type | For Profit - Corporation |
NPI Number | 1144236415 |
Organization Name | JOHNSON MEMORIAL HOSPITAL |
Doing Business As | THE WATERS OF WABASH SKILLED NURSING FACILITY WEST |
Address | 1720 Alber St, Wabash, IN 46992 |
Phone Number | 260-563-4112 |
News Archive
The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer.
MedQuist Inc., a leading provider of technology-enabled clinical documentation services, has announced an agreement with healthcare informatics software developer Artificial Medical Intelligence Inc. (AMI) to provide computer-assisted coding (CAC) within MedQuist's CodeRunner™ coding workflow platform.
Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med's proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.
› Verified 2 days ago
NPI Number | 1457069122 |
Organization Name | THE WATERS OF WABASH SKILLED NURSING FACILITY WEST LLC |
Address | 1720 Alber St, Wabash, IN 46992 |
Phone Number | 260-563-4112 |
News Archive
The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer.
MedQuist Inc., a leading provider of technology-enabled clinical documentation services, has announced an agreement with healthcare informatics software developer Artificial Medical Intelligence Inc. (AMI) to provide computer-assisted coding (CAC) within MedQuist's CodeRunner™ coding workflow platform.
Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med's proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer.
MedQuist Inc., a leading provider of technology-enabled clinical documentation services, has announced an agreement with healthcare informatics software developer Artificial Medical Intelligence Inc. (AMI) to provide computer-assisted coding (CAC) within MedQuist's CodeRunner™ coding workflow platform.
Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med's proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $9750 |
Number of Payment Denials | 1 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 7.37 | 14.46 |
Percentage of long-stay residents who lose too much weight | 2.13 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63.64 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.31 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.61 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.26 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 21.9 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 83.67 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 7.16 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.46 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 8.45 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.21 | 95.98 |
Percentage of short-stay residents who made improvements in function | 83.34 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 46.34 | 82.93 |
News Archive
The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer.
MedQuist Inc., a leading provider of technology-enabled clinical documentation services, has announced an agreement with healthcare informatics software developer Artificial Medical Intelligence Inc. (AMI) to provide computer-assisted coding (CAC) within MedQuist's CodeRunner™ coding workflow platform.
Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med's proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.
› Verified 2 days ago
Autumn Ridge Rehabilitation Centre Location: 600 Washington Ave, Wabash, Indiana 46992 Phone: (260) 563-8402 | |
Vernon Health & Rehabilitation Location: 1955 S Vernon St, Wabash, Indiana 46992 Phone: (260) 563-8438 |